c-erbB-4 protein expression in human breast cancer

British Journal of Cancer

Volumn 82, Issue 6, 2000, Pages 1163-1170

  Kew, T Y ^a   Bell, J A ^a   Pinder, S E ^a   Denley, H ^a   Srinivasan, R ^b   Gullick, W J ^b   Nicholson, R I ^c   Blamey, R W ^a   Ellis, I O ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c Tenovus Institute   (United Kingdom)

Author keywords

Breast cancer; c erbB 4; Growth factor receptor; Prognostic factors

Indexed keywords

GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; ONCOPROTEIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR BIOPSY;

EID: 0034053352     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1057     Document Type: Article

References (46)

1. Bacus SS, Chin D, Yarden Y, Zelnick CR and Stern DF (1996) Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors. Am J Pathol 148: 549-558
2. Baulida J, Kraus MH, Alimandi M, Di Fiore PP and Carpenter G (1996) All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J Biol Chem 271: 5251-5257
3. Bridges AJ (1996) The epidermal growth factor receptor family of tyrosine kinases and cancer: can an atypical exemplar be a sound therapeutic target? Curr Med Chem 3: 167-194
4. Busfield SJ, Michnick DA, Chickering TW, Revett TL, Ma J, Woolf EA, Comrack CA, Dussault BJ, Woolf J, Goodearl AD and Gearing DP (1997) Characterisation of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus. Mol Cell Biol 17: 4007-4014
5. Carpenter G (1987) Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem 56: 881-914
6. Carraway KL, Weber JL, Unger MJ, Ledesma J, Yu N, Gasmann M and Lai C (1997) Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 387: 512-516
7. Chang C-P, Lazar CS, Walsh BJ, Komuro M, Collawn JF, Kuhn LA, Tainer JA, Trowbridge IS, Farguhar MG, Rosenfeld MG, Wiley HS and Gill GN (1993) Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors. J Biol Chem 268: 19312-19320
8. Chang H, Riese DJ, Gilbert W, Stern DF and McMahan UJ (1997) Ligands for the ErbB family receptors encoded by a neuregulin-like gene. Nature 387: 509-512
9. Earp HS, Dawson TL, Lix and Yu H (1995) Heterodimerisation and functional interaction between EGF receptor family members: a new signalling paradigm with implications for breast cancer research. Breast Cancer Res Treat 35: 115-132
10. Elenius K, Paul S, Allison G, Sun J and Klagsbrun M (1997a) Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 16: 1268-1278
11. Elenius K, Corfas G, Paul S, Choi CJ, Rio C, Plowman GD and Klagsbrun M (1997b) A novel juxtamembrane domain isoform of HER4/ErbB4. J Biol Chem 272: 26761-26768
12. Ellis IO, Galea M, Broughton N, Locker A, Blamey RW and Elston CW (1992) Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20: 479-489
13. Elston CW and Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410
14. Faksvag Haugen DR, Akslen LA, Varhaug JE and Lillehaug JR (1996) Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. Cancer Res 56: 1184-1188
15. Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, Klein R and Lemke G (1995) Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378: 390-394
16. Gilbertson RJ, Perry RH, Kelly PJ, Pearson ADJ and Lunec J (1997) Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res 57: 3272-3280
17. Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI and Griffiths K (1982) A prognostic index in primay breast cancer. Br J Cancer 45: 361-366
18. Higashiyama S, Horikawa M, Yamada K, Ichino N, Nakano N, Nakagawa T, Miyagawa J, Matsushita N, Nagatsu T, Taniguchi N and Ishiguro H (1997) A novel brain derived member of the epidermal growth factor family that interacts with ErbB3 and ErbB4. J Biochem 122: 675-680
19. Hollywood DP and Hurst HC (1993) A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines. EMBO J 12: 2369-2375
20. erbB2. Science 256: 1205-1210
21. Kageyama R, Merlino T and Pastan I (1988) Epidermal growth factor (EGF) receptor gene transcription. Requirement for Sp1 and an EGF receptor-specific factor. J Biol Chem 263: 6329-6336
22. Klijn JGM, Berns PMJJ, Schmitz PIM and Foekens JA (1992) The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocrine Rev 13: 3-17
23. Komurasaki T, Toyoda H, Uchida D and Morimoto S (1997) Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene 15: 2841-2848
24. Knowlden JM, Gee JMW, Seery LP, Farrow L, Gullick WJ, Ellis IO, Blamey RWB, Robertson JFR and Nicholson RI (1998) c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer. Oncogene 17: 1949-1957
25. Lemoine NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E, Prigent SA, Gullick WJ and Hurst HC (1992) Expression of the ERBB3 gene-product in breast cancer. Br J Cancer 66: 1116-1121
26. Lewis S, Locker A, Todd JH, Bell JA, Nicholson R, Elston CW, Blamey RW and IO Ellis (1990) Expression of epidermal growth factor receptor in breast carcinoma. Clin Pathol 43: 385-389
27. Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD and Sliwkowski MX (1996) Growth regulation of human breast and ovarian tumor cells by heregulin: evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness. Cancer Res 56: 1457-1465
28. Li W, Park JW, Nuijens A, Sliwkowski MX and Keller GA (1996) Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells. Oncogene 12: 2473-2477
29. Lovekin C, Ellis IO, Locker A, Robertson JFR, Bell J, Nicholson R, Gullick WJ, Elston CW and Blamey RW (1991) C-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer 63:439-443
30. Lyne JC, Melham MF, Finley GG, Wen D, Liu N, Deng DH and Salup R (1997) Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro. Cancer J Scientific American 3: 21-30
31. Mason S and Gullick WJ (1995) Type 1 growth factor receptors: an overview of recent developments. The Breast 4: 11-18
32. Pereira H, Pinder SE, Sibbering DM, Galea MH, Elston CW, Blamey RW, Robertson JFR and Ellis IO (1995) Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 27: 219-226
33. Pinder SE, Ellis IO, Galea M, O'Rouke S, Blamey RW and Elston CW (1994) Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up, Histopath 24(1): 41-47
34. erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90: 1746-1750
35. erbB4. Nature 366: 473-475
36. Riese DJ, Bermingham Y, Van Raaij TM, Buckley S, Plowman GD and Stern DF (1996) Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-β. Oncogene 12: 345-353
37. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182
38. Srinivasan R, Poulsom R, Hurst HC and Gullick WJ (1998) Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Path 185: 236-245
39. Todd JH, Dowle C, Williams MR, Elston CW, Ellis IO, Hinton CP, Blamey RW and Haybittle JL (1987) Confirmation of a prognostic index in primary breast cancer. Br J Cancer 56: 489-492
40. Travis A, Pinder SE, Robertson JFR, Bell JA, Wencyk P, Gullick WJ, Nicholson RI, Poller DN, Blamey RW, Elston CW and Ellis IO (1996) C-erbB3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. British Journal of Cancer 74: 229-233
41. Vecchi M and Carpenter G (1997) Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism. J Cell Biol 139: 995-1003
42. Vecchi M, Baulida J and Carpenter G (1996) Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J Biol Chem 271: 18989-18995
43. Wen D, Suggs SV, Karunagaran D, Liu N, Cupples RL, Luo Y, Janssen AM, Ben-Baruch N, Trollinger DB and Jacobsen VL (1994) Structural and functional aspects of the multiplicity of neu differentiation factors. Mol Cell Biol 14: 1909-1919
44. Zhang D, Sliwkowski MX, Mark M, Frantz G, Akita R, Sun Y, Hillan K, Crowley C, Brush J and Godowski PJ (1997) Neuregulin 3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci USA 94: 9562-9567
45. Zhu X, Lai C, Thomas S and Burden SJ (1995) Neuregulin receptors, erbB3 and erbB4 are localized at neuromuscular synapses. EMBO J 14: 5842-5848
46. Zimonjic DB, Alimandi M, Miki T, Popescu NC and Kraus MH (1995) Localization of the human HER4/erbB-4 gene to chromosome 2. Oncogene 10: 1235-1237